Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FPAQS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,587
Award facts
- Contract value 100% obligated
- $2,587.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.
DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems, with a robust portfolio of contract awards predominantly serving the Defense Logistics Agency. The company has consistently leveraged its woman-owned small business status to compete effectively in federal procurement markets. The BOTOX delivery fulfills the DLA's requirement for pharmaceutical supplies critical to military medical operations, contributing to the company's established role as a key supplier in the federal pharmaceutical supply chain for Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FPAQS?
SPE2DB25FPAQS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FPAQS worth?
The government has obligated $2,587 on SPE2DB25FPAQS.
Is contract SPE2DB25FPAQS an order under another contract?
Yes. SPE2DB25FPAQS is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQS competed?
The extent of competition for SPE2DB25FPAQS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award